<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03246984</url>
  </required_header>
  <id_info>
    <org_study_id>CD0097</org_study_id>
    <nct_id>NCT03246984</nct_id>
  </id_info>
  <brief_title>VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ</brief_title>
  <acronym>VALUE</acronym>
  <official_title>A Post Market Surveillance Multi-center Prospective Study to Evaluate the Safety and Efficacy of the VasQ External Support for Arteriovenous Fistula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laminate Medical Technologies</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laminate Medical Technologies</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective single arm study enrolling patients who are scheduled for creation of a
      new Brachiocephalic AV fistula. Up to 50 patients will be enrolled. All patients will be
      implanted with the VasQ device, a subcutaneous arteriovenous conduit support for vascular
      access. The follow up period in this study will be for a duration of 12 months, with follow
      up visits scheduled at 1, 3, 6, 9, and 12 months.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 7, 2017</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary patency of AV fistula</measure>
    <time_frame>6 months post AVF creation</time_frame>
    <description>Freedom from any intervention designed to maintain or reestablish patency since device placement and demonstrate flow on Doppler US.
1 = Success = Intervention free access patency determined by Doppler ultrasound.
0 = Failure = Access occluded determined by Doppler ultrasound and/or underwent intervention</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Arterio-Venous Fistula</condition>
  <condition>Kidney Failure, Chronic</condition>
  <condition>Kidney Diseases</condition>
  <condition>Renal Failure Chronic</condition>
  <condition>ESRD</condition>
  <condition>Arteriovenous Fistula Thrombosis</condition>
  <arm_group>
    <arm_group_label>VasQ device implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VasQ</intervention_name>
    <description>VasQ device implantation in patients with a new brachio-cephalic fistula creation .</description>
    <arm_group_label>VasQ device implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients referred for creation of a new brachiocephalic fistula who consent to take
             part in the study.

          -  Patients willing and able to attend follow up visits over a period of 12 months

        Exclusion Criteria:

          -  Patients with the planned index procedure being a revision surgery of an existing
             fistula.

          -  Target artery smaller than 3 mm or larger than 6 mm

          -  Target vein smaller than 3 mm

          -  Significantly stenotic target vein on the side of surgery

          -  Unusual anatomy or vessel dimensions and which preclude adequate fit of the VasQ.

          -  Patients with prior central venous stenosis or obstruction on the side of surgery

          -  Depth of vein greater than 8 mm (on ultrasound) on side of surgery

          -  Known coagulation disorder

          -  Congestive heart failure NYHA class ≥ 3

          -  Prior steal on the side of surgery

          -  Known allergy to nitinol

          -  Life expectancy less than 18 months

          -  Patients expected to undergo kidney transplant within 6 months of enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noam Zilberman</last_name>
    <role>Study Director</role>
    <affiliation>Laminate Medical Technologies Ltd.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maya Vizel, M.Sc.</last_name>
    <phone>+972-3-6344246</phone>
    <phone_ext>312</phone_ext>
    <email>Maya@laminatemedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Uri Heiman, Dr.</last_name>
    <phone>+972-3-6344246</phone>
    <phone_ext>301</phone_ext>
    <email>Uri@laminatemedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Königin Elisabeth Krankenhaus Herzberge</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans Scholz, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Chemnitz gGmbH</name>
      <address>
        <city>Chemnitz</city>
        <zip>09113</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sven Seifert, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Cologne</name>
      <address>
        <city>Cologne</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Brunkwall, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Elisabeth-Krankenhaus Essen</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juergen Zanow, PD Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Ernst von Bergmann gemeinnützige GmbH</name>
      <address>
        <city>Potsdam</city>
        <zip>14467</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Olschewski, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Harzklinikum Dorothea Christiane Erxleben</name>
      <address>
        <city>Wernigerode</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torsten Mildner, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic of Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gaspar Mestres, Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.laminatemedical.com/</url>
  </link>
  <reference>
    <citation>Chemla E, Velazquez CC, D'Abate F, Ramachandran V, Maytham G. Arteriovenous fistula construction with the VasQ™ external support device: a pilot study. J Vasc Access. 2016 May 7;17(3):243-8. doi: 10.5301/jva.5000527. Epub 2016 Apr 14.</citation>
    <PMID>27079670</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2017</study_first_submitted>
  <study_first_submitted_qc>August 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2017</study_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

